You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

SURMONTIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Surmontil, and what generic alternatives are available?

Surmontil is a drug marketed by Odyssey Pharms and is included in one NDA.

The generic ingredient in SURMONTIL is trimipramine maleate. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the trimipramine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Surmontil

A generic version of SURMONTIL was approved as trimipramine maleate by ELITE LABS INC on August 2nd, 2006.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SURMONTIL?
  • What are the global sales for SURMONTIL?
  • What is Average Wholesale Price for SURMONTIL?
Drug patent expirations by year for SURMONTIL
Drug Prices for SURMONTIL

See drug prices for SURMONTIL

US Patents and Regulatory Information for SURMONTIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Odyssey Pharms SURMONTIL trimipramine maleate CAPSULE;ORAL 016792-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Odyssey Pharms SURMONTIL trimipramine maleate CAPSULE;ORAL 016792-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Odyssey Pharms SURMONTIL trimipramine maleate CAPSULE;ORAL 016792-003 Sep 15, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.